Research analysts at Redburn Atlantic began coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) in a ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Buy ...

Equities research analysts at Redburn Atlantic began coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) in a research note issued on Monday, Marketbeat.com reports. The firm set a ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of Alnylam Pharmaceuticals (NasdaqGS:ALNY) with a ...

Redburn Atlantic initiated coverage of BridgeBio with a Buy rating and $50 price target Therapeutic options for patients with transthyretin ...

Reddit has grown quickly since going public last year, but some analysts warn that its growth could be dependent on Google ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of Ionis Pharmaceuticals (NasdaqGS:IONS) with a Neutral recommendation. As of March 19, 2025, the average one-year price ...

Reddit Inc.’s stock has enjoyed significant gains since the social-media company’s initial public offering a year ago, buoyed ...

Over the past year, Reddit’s stock has seen significant volatility, with a 52-week low of $37.35 and a high of $230.41. Despite the current bearish outlook from Redburn, analyst recommendations remain ...

User growth has been driven largely by logged-out users accessing the platform via Google Search, a trend that has ...

Fintel reports that on March 31, 2025, Redburn Atlantic initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Buy recommendation. As of March 19, 2025, the average one-year price target ...